Comprehensive Financial Consultants Institutional, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Comprehensive Financial Consultants Institutional, Inc.

$243 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $10,712 - $12,571	-18 Closed	0 $0
Q4 2021 Mar 10, 2022	BUY	$543.48 - $670.97 $9,782 - $12,077	18 New	18 $11,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$9.45 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$8.88 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$8.7 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$5.09 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.88 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.

Account